Stay updated on Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page.

Latest updates to the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check27 days agoChange DetectedRemoval of the government funding delay banner from the page; this does not affect the study details or trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedAdministrative updates to the study record, including a newer last update date and results posting information, with no changes to the study design or eligibility criteria.SummaryDifference0.4%

- Check71 days agoChange DetectedAdded a government-status notice and a v3.2.0 revision; removed the v3.1.0 revision. The page now informs users about potential delays and where to check current operating status, and indicates the new version.SummaryDifference2%

- Check78 days agoChange DetectedPage version updated from v3.0.2 to v3.1.0; removal of the term 'Liver Cancer'.SummaryDifference1.0%

- Check92 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1. The Back to Top link has been removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page.